Efficacy and safety of hemodilutional autologous blood transfusion for intermediate- to advanced- liver resection : An observational study

JRCT ID: jRCT1050220063

Registered date:14/07/2022

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: All disease which would be required for hepatectomy
• Date of first enrollment: 14/07/2022
• Target sample size: 50
• Study type: Observational

Outcome(s)

• Primary Outcome: Intraoperative allogeneic blood transfusion

Secondary Outcome

Intraoperative setting: bleedings(before and after HAT), amont of loss of Hb, coagulation test
Postoperative setting: Complications according to the Clavien-Dindo classification, allogeneic blood transfusion (amount or rate), posthepatectomy liver failure (PHLF)

Key inclusion & exclusion criteria

• Age minimum: >= 18age old
• Age maximum: Not applicable
• Gender: Both

Include criteria

1. More than 18 years
2. All disease which would be required for hepatectomy
3. intermediate-to-difficult hepatectomy
4. HAT cases

Exclude criteria

1. Hepatectomy with concomitant some surgery (e.g., gastrectomy or pancreaticoduodenecrtomy)
2. Donor hepatectomy

Related Information

• Primary Sponsor: Uchida Yoichiro